SUNNYVALE, Calif., Oct. 27 /PRNewswire/ — Accuray Incorporated
(Nasdaq:
ARAY), a global leader in the field of radiosurgery, today
announced that the Korea Cancer Care Hospital (KCCH) in Seoul,
South Korea has installed its second CyberKnife® Robotic
Radiosurgery System, marking the first hospital in the country
– and Asia – to have two CyberKnife Systems in use.
The recently acquired CyberKnife System is located at the Asia
Cancer Center (ACC), the new cancer hospital of KCCH located in
Busan. It represents the eighth CyberKnife System in South Korea
and the country’s first equipped with a linear accelerator capable
of delivering a dose rate of 1,000MU (monitor unit) per minute,
which improves the system’s efficiency.
“We are very pleased to be the first hospital in South Korea
with two CyberKnife Systems in use,” said Dr. Kwang Mo Yang, Chief
of Cancer Research Division and Radiation Oncologist at ACC. “The
CyberKnife System, a state-of-the-art form of cancer care will
enable us to expand our radiation offerings to patients who may not
have been able to tolerate other treatments or have medically or
surgically inoperable tumors. With this additional capability at
ACC, the CyberKnife System is a definite asset for our treatment
program, offering an alternative to our patients and establishing
the ACC’s role as ‘The First Medical Hub of Asia.'”
“We are very proud that the CyberKnife System has been serving
Korean patients and KCCH, one of the most prestigious cancer care
and research institutes, for eight years,” said Cynthia Chan,
Director of Marketing, Accuray APAC. “CyberKnife technology is
increasingly accepted by the medical community in Korea. The second
CyberKnife System with the newest product enhancements now being
used at ACC not only broadens patient access, but also contributes
to the clinical development of radiosurgery and high
‘/>”/>
